Work

Exploratory PML risk assessment on Extended Interval Natalizumab Dosing. (P5.374)

Year: 2017

Type: article

Source: Neurology

DOI: 10.1212/wnl.88.16_supplement.p5.374

Authors: Lana Zhovtis Ryerson, John Foley, Ilya Kister, Teresa Frohman, Krupa Pandey, Xiaochun Lu, Judith Goldberg, Guadalupe Zuniga - Estrada, Tammy Hoyt, April Jacob, Tamar Bacon, Eugene Major, Elliot Frohman

Institutions: New York University, Rocky Mountain Multiple Sclerosis Clinic, The University of Texas Southwestern Medical Center, Saint Barnabas Medical Center, National Institute of Neurological Disorders and Stroke

Language: English

Topic: Polyomavirus and related diseases

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4389444710

FWCI:

Cites:

Cited by:

Related to: 10